Al-Dahi, W. A., Khalaf, S. H., AlRomaihi, D. A., Alamuddin, N. M.
, al Kandari, H. M., Abdalla, D. K., Alfadehla, H. Y., Jayyousi, A. A., Siddique, M. A., AlAlami, U. A., Subbarao, G. C., Chetty, S. J., & Abdulla, J. A. (2025).
glp-1ra and sglt2i utilization in people with type 2 diabetes with atherosclerotic cardiovascular disease (ascvd) or at high risk of ascvd in the gulf region results from the pact-mea studys.
Saudi Medical Journal,
46(2), 163-170.
https://doi.org/10.15537/smj.2025.46.2.20240620